Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-16

Clinical Trial Update: The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating oral aminophylline and ambrisentan, both alone and in combination, in healthy volunteers to assess tolerability and potential …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aminophylline (aminophylline)
  • LETAIRIS (ambrisentan)

Snippet

Sponsor: Thies Schroeder | Conditions: High Altitude Pulmonary Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2014-01-16